drugset / Trial / NCT02715505
Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to assess the safety and exploratory efficacy of using HSC835 in patients with Inherited Metabolic Disorders (IMD) undergoing stem cell transplantation.
Timeline
- Start
- 2017-10-10
- Primary completion
- 2020-05-18
- Completion
- 2020-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSC835 | Cell therapy | — | — |